NRSN
NeuroSense Therapeutics Ltd

3,628
Mkt Cap
$26.43M
Volume
410,671.00
52W High
$2.60
52W Low
$0.81
PE Ratio
-1.52
NRSN Fundamentals
Price
$0.8385
Prev Close
$0.89
Open
$0.87
50D MA
$1.10
Beta
0.58
Avg. Volume
393,586.42
EPS (Annual)
-$0.5489
P/B
8.00
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026
NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026 NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026 PR Newswire CAMBRIDGE, Mass., Dec. 4, 2025 CAMBRIDGE, Mass...
PR Newswire·12d ago
News Placeholder
NeuroSense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for PrimeC in ALS
NeuroSense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for PrimeC in ALS NeuroSense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for PrimeC in ALS PR Newswire CAMBRIDGE...
PR Newswire·21d ago
<
...
1
>

Latest NRSN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.